Bloomberg Bond Traders Choose At any time-Riskier Bets in Hunt for Returns (Bloomberg) — Bond buyers, emboldened by a recovering financial system and a worldwide
Tag: Therapeutics
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
– Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta thalassemia (TDT)- -More than 30 patients have been dosed with
Peptide Cancer Therapy Market Therapeutics Drug Revenue Patent Price tag USD 20 Billion Option 2026
Bloomberg Europe’s Most Indebted Nations around the world Are not All set for Sector Reality (Bloomberg) — Europe’s brightening economic outlook as Covid-19 vaccinations decide
Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Management to host conference call today at 5:00 pm ET AUSTIN, Texas, April 22, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”),
Aquestive Therapeutics to Report To start with Quarter 2021 Money Success and Latest Business Highlights on May possibly 4 and Host Meeting Call on May 5 at 8:00 a.m. ET
WARREN, N.J., April 21, 2021 (Globe NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical organization centered on producing and commercializing differentiated products that deal
Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020
Bloomberg Central Banks to Pour Money Into Economy Despite Sharp Rebound (Bloomberg) — The aggressive rebound in global economic growth still isn’t enough for most
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Fiscal Officer
TipRanks 3 “Strong Buy” Dividend Stocks Yielding Close to 7% These past 12 months have observed the S&P 500 return its very best performance ever
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Fiscal Officer
SAN DIEGO, April 19, 2021 /PRNewswire/ — Himalaya Therapeutics (“Himalaya”), a clinical-stage biopharmaceutical company targeted on growth and commercialization in Higher China of a novel course
Human Microbiome Therapeutics Marketplace Report 2021-2031
Forecasts by Engineering (Genomics, Proteomics, Metabolomics), by Therapeutic Area (Neurological Disorders, Dermatological Indications, Cancers, Metabolic Problems, Gastrointestinal Problems, Other Therapeutic Places), by Variety (Faecal Microbiota
Chinook Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
SEATTLE, April 07, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines